Table 1 Patient characteristics at the time of primary diagnosis of breast cancer
|  | Patients (%) | LOH (%)§ | DTC (%)$ |
|---|---|---|---|
Total | 81 | 27 (33.5) | 32 (39.5) |
Age | 56 years (range 33-81) | Â | 24 (41) |
Family history | Â | Â | 4 (31) |
   negative | 58 (73) | 21 (36) | 4 (50) |
   positive | 13 (17) | 5 (39) |  |
   unknown | 8 (10) | 1 (13) | 28 (37) |
Patient subgroup | Â | Â | Â |
   M0 | 76 (94) | 27 (36) |  |
   M1 | 5 (6) | 0 (0) | 4 (80) |
Tumor size | Â | Â | Â |
   pT1 | 33 (41) | 14 (42) | 11 (33) |
   pT2 | 39 (48) | 12 (31) | 17 (44) |
   pT3-4 | 9 (11) | 1 (11) | 4 (44) |
Nodal status | Â | Â | Â |
   pN0 | 49 (62) | 19 (39) | 21 (43) |
   pN1-2 | 30 (38) | 8 (27) | 10 (33) |
Histology | Â | Â | Â |
   Ductal | 60 (75) | 23 (38) | 20 (33) |
   Lobular | 10 (12.5) | 3 (30) | 6 (60) |
   Others* | 10 (12.5) | 1 (10) | 6 (60) |
Grading | Â | Â | Â |
   I-II | 51 (65) | 23 (45) | 21 (41) |
   III | 28 (35) | 4 (14) | 10 (36) |
ER status | Â | Â | Â |
   negative | 23 (28.5) | 6 (26) | 9 (39) |
   positive | 58 (71.5) | 21 (36) | 23 (40) |
PR status | Â | Â | Â |
   negative | 29 (36) | 8 (28) | 8 (28) |
   positive | 52 (64) | 19 (37) | 24 (46) |
CEA | Â | Â | Â |
   negative | 69 (86) | 25 (36) | 27 (39) |
   positive | 11 (14) | 2 (18) | 5 (46) |
CA15-3 | Â | Â | Â |
   negative | 67 (84) | 25 (37) | 27 (40) |
   positive | 13 (16) | 2 (15) | 5 (39) |
Therapy | Â | Â | Â |
   BCT | 45 (56) | 20 (44) | 14 (31) |
   Ablation | 36 (44) | 7 (22) | 18 (50) |